NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply. -
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) (RFA-CA-22-020) Application Receipt Date(s): June 17, 2022 -
Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed) (RFA-AI-22-020) Application Receipt Date(s): July 1, 2022 -
Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed) (RFA-OD-22-008) Application Receipt Date(s): July 1, 2022 -
A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed)(RFA-EY-22-001) Application Receipt Date(s): July 6, 2022 -
Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) (PAR-22-147) Application Receipt Date(s): July 8, 2022 -
Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed) (RFA-AI-22-028) Application Receipt Date(s): July 29, 2022 -
Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional) (RFA-CA-22-016) Application Receipt Date(s): September 27, 2022 -
Alcohol Health Services Research (R01 Clinical Trial Optional) (PAR-22-156) Application Receipt Date(s): Multiple dates, see announcement. -
Alcohol Health Services Research (R34 Clinical Trial Optional) (PAR-22-157) Application Receipt Date(s): Multiple dates, see announcement. -
Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) (PAR-22-158) Application Receipt Date(s): Multiple dates, see announcement. -
Alcohol Treatment and Recovery Research (R34 Clinical Trial Required) (PAR-22-159) Application Receipt Date(s): Multiple dates, see announcement. -
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) (RFA-OD-22-007) Application Receipt Date(s): Multiple dates, see announcement. -
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)) (RFA-OD-22-009) Application Receipt Date(s): Multiple dates, see announcement. -
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) (RFA-OD-22-010) Application Receipt Date(s): Multiple dates, see announcement. -
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) (PAR-22-161) Application Receipt Date(s): Multiple dates, see announcement. -
Laboratories to Optimize Digital Health (R01 Clinical Trial Required) (PAR-22-154) Application Receipt Date(s): Multiple dates, see announcement. NIH funding opportunities for which foreign components may apply: Other Funding News General NIH notices that may be of interest to global health researchers: Notice of changes to funding opportunities that may be of interest to global health researchers: Notices of intent to publish funding opportunities that may be of interest to global health researchers: Non-NIH funding opportunities that may be of interest to global health researchers: Featured Fogarty News and Information Other NIH News Events Training and events for global health researchers: More Information |
No comments:
Post a Comment